However, EGFR-Thr790Met was more frequent in male patients (66.7% vs. 33.3%), in patients without bone metastasis (88.9% vs. 11.1%) and in older patients (77.8% vs. 22.2%). This evidence concerns the gene EGFR and bone metastasis.